Tag: pharmaceuticals
-
Plasma Infusions to Treat Alzheimer’s Shown Safe
Results from a small-scale clinical trial indicate treatments with plasma infusions from young donors are safe for patients and may improve functional abilities.
-
Start-Up Formed to Develop Non-Opioid Pain Drugs
A new enterprise is being formed to develop non-addictive drugs for chronic pain that use different biochemical processes than opioid pain relievers.
-
Lab-On-Chip Device Simulates Tumor Microenvironment
Biomedical engineers designed a device that simulates the supportive environment in which tumors grow, and in tests was shown to work as well as lab mice for assessing cancer drugs.
-
Report – 126 Alzheimer’s Drugs in Clinical Trials
A foundation supporting research on new drugs to treat Alzheimer’s disease says clinical trials now underway are testing 126 potential therapies for the disorder.
-
Cancer Drug Price Rises Shown Unrelated to Competition
An analysis of cancer drugs shows their prices steadily increased over 16 years despite competition from newer drugs on the market.
-
RNA Meds Companies Partner on Human, Animal Vaccines
Synthetic Genomics Inc. and Arcturus Therapeutics Inc. are collaborating on longer-lasting and more robust RNA therapies and vaccines for humans and animals.
-
Artificial Beta Cells Shown to Produce Insulin as Needed
A biomedical engineering team developed artificial beta cells that in animal tests perform similar to natural cells in the pancreas to produce insulin as needed for controlling blood glucose levels.
-
Novartis Acquires Nuclear Meds Developer in $3.9B Deal
Drug maker Novartis is purchasing a company that develops therapies and diagnostics using radio isotopes for neuroendocrine and other cancers.
-
Here’s What a Real Opioid Emergency Looks Like
Let’s be clear — the limited steps ordered by the president to reduce the numbers of people addicted to opioids don’t look anything like a response to an emergency.
-
Project to Develop Universal Flu Vaccine
An initiative joining academic, private, and national labs is designing a vaccine that covers all influenza strains, with clinical studies expected to begin early next year.